Feride Yılmaz

5PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersNutrigenomics and personalised nutritionMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 26, 2026
Clinical Characteristics and Survival Outcomes of a Clinically Defined Treatment-Emergent Neuroendocrine/Aggressive-Variant Prostate Cancer Phenotype: A Retrospective Study.

|Aug 14, 2025
A Promising Prognostic Indicator for Pleural Mesothelioma: Pan-Immuno-Inflammation Value.

Serkan Yaşar, Feride Yılmaz, Ömer Denizhan Tatar

|Jun 27, 2025
Prognostic Nutritional Index and a Blood-Based Prognostic Tool in Prostate Cancer Treated with Abiraterone, Enzalutamide or Cabazitaxel.

Hakan Taban, Mustafa Erman, Deniz Can Guven

|Sep 24, 2024
Real-Life Experience with Entrectinib in Neurotrophic Tyrosine Receptor Kinase Fusion-Positive Solid Tumors: A Multicenter Retrospective Trial.

Feride Yılmaz, Serkan Yaşar, Nil Molinas Mandel

|Sep 09, 2022
Blood Based Biomarkers as Predictive Factors for Hyperprogressive Disease.

Hasan Cagri Yildirim, Deniz Can Guven, Oktay Halit Aktepe

Pageof 1

Frequent Collaborators

3 joint publications

Hasan Çağrı Yıldırım

3 joint publications

Deniz Can Guven

3 joint publications

Serkan Yasar

2 joint publications

Burak Yasin Aktas